Neuprex recombinant bactericidal/permeability-increasing protein 21 (rBPI21): Phase III Update

Xoma Corp. (XOMA), Berkeley, Calif.
Product:

Read the full 60 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE